Peter is a doctor from Ireland who is completing his higher specialist training in paediatrics. He is a part of the Oxford Vaccine Group and has worked across a variety of clinical trials involving typhoid fever, pneumococcal and COVID-19 vaccines. He is planning to start his PhD in the use of transcriptomics in infectious diseases later this year.

I am a medical doctor with a Msc in Epidemiology. I have over 10 years’ experience in the conduct and management of clinical trials and observational studies in low resource settings; in Kenya and Uganda.

Victoria Olarewaju is a graduate student studying Epidemiology at the Swiss Institute of Tropical and Public Health, Basel Switzerland. She has her academic background in Microbiology and Public health. Her research interests include vaccine behavior, adolescent sexual health and social determinants of health. She has authored and co-authored several academic publications.

Laura Olbrich is a clinician-scientist with a paediatric background working on childhood TB. Dr Olbrich completed her medical studies in Bochum, Germany, and spent extensive periods abroad, mostly in sub-Saharan Africa and South America. Her main research interest is the evaluation of new diagnostic approaches and tests, aiming to identify reliable diagnostic solutions for low ressource settings. Currently, Dr Olbrich is the coordinating scientifist of the multi-country RaPaed-AIDA-TB project, a large prospective study evaluating a number of diagnostic tests for TB in children aiming to enrol a total of 1,000 children in five countries. In addition, she is a third-year DPhil student at the Oxford Vaccine Group at the University of Oxford.

Saad B. Omer is the Director of the Yale Institute for Global Health, and a Professor of Medicine and Epidemiology at Yale University, Schools of Medicine and Public Health. He has conducted studies in the United States, Guatemala, Kenya, Uganda, Ethiopia, India, Pakistan, Bangladesh, and South Africa. Dr Omer’s research portfolio includes epidemiology of respiratory viruses such as influenza, RSV, and - more recently - SARS-Cov-2 (COVID-19); clinical trials to estimate efficacy of maternal and/or infant influenza, pertussis, polio, measles and pneumococcal vaccines; and trials to evaluate drug regimens to reduce mother-to-child transmission of HIV He has published over 340 papers in peer reviewed journals and has mentored over 100 junior faculty, clinical, and research post-doctoral fellows and PhD and other graduate students.

I am a neonatologist in Eskisehir Osmangazi University Hospital.

My interest in research is primarily guided by the need for improving care for the child at risk for serious infections. This drives the interest in identifying biomarkers of serious infections, developing tools to support physicians in decisions on management and parents in their decisions of help-seeking behavior. Specific research areas are to improve the recognition of serious illness in the febrile child: i) evaluation of diagnostic value of predictors of serious infections (clinical signs and symptoms, vital signs, inflammatory markers) in febrile children; ii) Implementation of decision support in febrile children at the paediatric emergency department; iii) Safetynetting for febrile children and improving parental information on serious illness; iv) developing methods for studies on routine data using automatic dataextraction. Cooperation with the Department of Medical Informatics and Department of Public Health, ErasmusMC. International collaboration within the REPEM group (Research European Pediatric Emergency Medicine) National collaboration with the PEM-NL group.

Anna Ostrzewska graduated from Wroclaw Medical University (Poland) and obtained postgraduate diploma in Clinical Microbiology and Infectious Diseases at University of Edinburgh. She is a paediatric trainee in East Midlands (UK). Currently she is working as a clinical research fellow and paediatric infectious diseases registrar at St Mary's Hospital, Imperial College London.

Apr 2019 – Present Fellowship, Division of Infectious diseases, Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan Apr 2016 – March 2019 Senior Resident, Department of Pediatrics, Matsudo City General Hospital, Chiba, Japan Apr 2014 – March 2016 Junior Resident, Showa General Hospital, Tokyo, Japan

Dr Ouldali is currently working as senior pediatrician in the general pediatrics and pediatric infectious disease department of Robert Debré university hospital, Paris University, France. The main topic of his PhD was the epidemiology of pneumococcal diseases in children and serotype replacement in PCV13 era. He also took part in assessing SARS-CoV-2 related diseases in children in France, especially clinical and therapeutic aspects of MIS-C.